Company Analysis

Lisata Therapeutics, Inc. (LSTA)

Nasdaq: LSTA · Pharmaceutical Preparations · Basking Ridge, NJ · filing with the SEC since 1995
Grade4.2
◀ Past 3.8● Present 4.5▶ Future 4.2
2 est.

Who runs Lisata Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Mazzo David J
President & CEO. First filing Jan 2015, latest Jan 13, 2026, 0 filings in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
24 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Lehrer-Graiwer JoshuaPresident & COOSep 2026Sep 28, 2026none
Mazzo David JPresident & CEOJan 2015Jan 13, 2026none
Nisco JamesSVP, Fin/Treas, Chief Actg OffApr 2024Jan 13, 2026none
Buck Kristen KEVP, R&D and CMOSep 2021Jan 13, 2026none
Imam TariqSVP, Bus Dev, General CounselFeb 2025Jan 13, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Love Ted WdirectorSep 2026Sep 28, 2026none
Azab MohammaddirectorSep 2022Jan 13, 2026none
Brown Gregory BdirectorOct 2016Jan 13, 2026none
Henson HeididirectorSep 2022Jan 13, 2026none
Klosk Steven MdirectorJul 2014Jan 13, 2026none
Schwalm CynthiadirectorNov 2018Jan 13, 2026none
Earlier names on the record16, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton LSTA · research, not advice